ABBV vs JNJ: Which Stock is Better?
Side-by-side comparison of AbbVie Inc and Johnson & Johnson in 2026
Comparison Updated:
ABBV
AbbVie Inc
$220.04
JNJ
Johnson & Johnson
$209.72
Key Metrics Comparison
| Metric | ABBV | JNJ | Winner |
|---|---|---|---|
| Market Cap | $388.97B | $492.44B | JNJ |
| P/E Ratio | 166.73 | 19.77 | JNJ |
| EPS (TTM) | $1.32 | $10.34 | JNJ |
| Revenue Growth | 0.1% | 0.1% | ABBV |
| Gross Margin | 71.5% | 68.4% | ABBV |
Analyze ABBV
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABBV or JNJ a better investment?
Comparing ABBV and JNJ: AbbVie Inc has a market cap of $388.97B while Johnson & Johnson has $492.44B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABBV and JNJ?
ABBV (AbbVie Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABBV or JNJ?
Based on P/E ratios, JNJ trades at a lower multiple (19.8x vs 166.7x).